Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000663065 | SCV000786128 | likely benign | Colorectal cancer, susceptibility to, 12 | 2018-03-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001565685 | SCV001789079 | likely benign | not provided | 2020-01-16 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001565685 | SCV003283623 | likely benign | not provided | 2024-11-06 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001357850 | SCV001553439 | likely benign | Polymerase proofreading-related adenomatous polyposis | no assertion criteria provided | clinical testing | The POLE c.1474-13G>A variant was not identified in the literature nor was it identified in the dbSNP database. The variant was only identified in ClinVar (classified as likely benign by Counsyl). The variant was not identified in the following control databases: the Exome Aggregation Consortium (August 8th 2016) or the Genome Aggregation Database (Feb 27, 2017). The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. |